DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Ro - 3 Zachariah Reitano - 3 Reitano - 3 Eli Lilly - 2 She'd - 2 it's - 2 Michael Siluk - 1 Gray Beard - 1
Top related locs:
U.S Charlotte , North Carolina Dudley , North Tyneside Britain Collegeville , Pennsylvania Hims Xinhua New York
Top related orgs:
Novo Nordisk - 2 CNBC - 2 Wednesday - 1 U.S - 1 U.S . Food - 1 Drug Administration - 1 — Novo - 1 UCG - 1

Search resuls for: "Zachariah Reitano"


6 mentions found


☆ Telehealth company Ro launches GLP-1 supply tracker to help patients navigate shortages
  + stars: | 2024-05-29 | by ( Annika Kim Constantino Ashley Capoot | Annika Kim Constantino | Ashley Capoot | ) www.cnbc.com   time to read: +2 min
Telehealth company Ro on Wednesday launched a new tracker to help patients find a popular class of weight loss and diabetes drugs called GLP-1s amid shortages of those treatments in the U.S. The supply tracker could be a valuable tool for many Americans scrambling to get their hands on GLP-1s, such as Novo Nordisk 's weight loss injection Wegovy and diabetes drug Ozempic. The tracker aims to make GLP-1 supply information more transparent and accessible for everyone, regardless of whether they are enrolled in any of Ro's programs. The tracker is an interactive tool that gives people real-time supply information by drug, dose size and pharmacy location. He added that opening up the tracker to everyone also makes it more likely for both Ro patients and people not enrolled in the company's programs to access GLP-1s.
Persons: Ro, Eli Lilly, Zachariah Reitano, Reitano Organizations: Wednesday, U.S, Novo Nordisk, U.S . Food, Drug Administration, CNBC Locations: U.S
☆ How digital health companies are capitalizing on the GLP-1 boom
  + stars: | 2024-05-25 | by ( Annika Kim Constantino Ashley Capoot | Annika Kim Constantino | Ashley Capoot | ) www.cnbc.com   time to read: +14 min
In addition to Wegovy and Ozempic, the GLP-1 class includes Eli Lilly's highly popular weight loss drug Zepbound and diabetes treatment Mounjaro. VanGilder signed up nearly four years ago and started taking the weekly diabetes injection Ozempic specifically for weight loss. The big difference between Calibrate and prior weight loss efforts, VanGilder said, is that she doesn't feel like she's dieting. Calibrate is one of the only companies to regularly release reports detailing the results of its weight loss program. The federal Medicare program by law can't cover weight loss drugs unless the prescription is for another approved health benefit, such as diabetes or cardiovascular health.
Persons: Michael Siluk, Gray Beard, She'd, that's, Beard, wouldn't, She's, Ro, Goldman Sachs, Eli Lilly's, it's, Andrew Dudum, There's, Zachariah Reitano, Reitano, Wegovy, WeightWatchers, Gary Foster, Foster, Oprah Winfrey's, Kim Gradwell, Lee Smith, Jennifer VanGilder, she'd, Jenny Craig, VanGilder, I've, Kristin Baier, Rob MacNaughton, Ro's Reitano, we'd, Eli Lilly, Craig Primack, Primack, Hims, Dudum, We're Organizations: — Novo, UCG, Novo Nordisk, CNBC, Teladoc Health, World Health Organization, Food, WeightWatchers Clinic, Ursinus College, Asset Management Locations: Charlotte , North Carolina, U.S, Dudley , North Tyneside, Britain, Collegeville , Pennsylvania, Hims
☆ A $7 billion startup wanted to build patient-friendly healthcare. Its bet on buzzy weight-loss drugs is testing that vision.
  + stars: | 2023-06-29 | by ( Blake Dodge | Rebecca Torrence | ) www.businessinsider.com   time to read: +12 min
Patient complaints go beyond the Wegovy shortageKaitlyn's complaints echo an array of issues faced by other Ro patients seeking weight-loss drugs. The patients Insider interviewed asked to be identified by their first names to protect their privacy. In this chat log, a Ro weight-loss patient sends messages to the startup asking to cancel the program. Reitano told Insider that around 90% of Ro patients got a response within 24 hours. "Until these DTC companies generally start getting into the muck of healthcare, they're not going to have a material impact," Parker told Insider.
Persons: Ro, Zachariah Reitano, Reitano, Li Ran, Robyn Phelps, Kaitlyn, She'd, didn't, she's, couldn't, Max Kerwick, drugstores, Max, Ro's, aren't, hasn't, Florian Gaertner, it's, TJ Parker, they're, Parker Organizations: New York, Getty, Better Business Bureau, Nordisk, Better Business, CareMetx, Ro, TechCrunch Locations: Xinhua, New York, New York City
☆ How buzzy weight-loss drugs like Ozempic became the next craze in the hottest part of healthcare
  + stars: | 2023-03-14 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +7 min
Healthcare companies are launching programs left and right to prescribe trendy weight-loss drugs. And Ro, a startup that prescribes and sells products like Viagra and hair-loss pills to consumers, is going all in with a program it launched in January to prescribe the weight-loss drugs to patients online. CalibrateFirst developed to manage type 2 diabetes, GLP-1 medications regulate blood-sugar levels, which can help people curb cravings and feel fuller after eating. The weight-loss market for GLP-1 drugs is relatively new, and not everyone is on board. But for some companies, stepping into prescribing these new weight-loss medications seems to simply be the natural next step for growth.
☆ Why buzzy weight-loss drugs are the next craze for healthcare startups
  + stars: | 2023-03-13 | by ( Rebecca Torrence | ) www.businessinsider.com   time to read: +7 min
Healthcare companies are launching programs left and right to prescribe trendy weight-loss drugs. And Ro, a startup that prescribes and sells products like Viagra and hair-loss pills to consumers, is going all in with a program it launched in January to prescribe the weight-loss drugs to patients online. Even startups like Noom, which quietly started a program prescribing GLP-1 medications, could stand to benefit from the drugs' popularity after a tumultuous year for the startup. The weight-loss market for GLP-1 drugs is relatively new, and not everyone is on board. But for some companies, stepping into prescribing these new weight-loss medications seems to simply be the natural next step for growth.
☆ New weight loss drugs trending with billionaires and celebrities are about to enter more American homes
  + stars: | 2023-01-20 | by ( Barbara Collins | ) www.cnbc.com   time to read: +8 min
GLP-1s also have been found to help with weight loss as they make individuals who use them feel fuller for a longer period of time. Using GLP-1s drug injections for weight loss has become one of the latest ways some big names in the market are shedding extra pounds. That's why his company has launched a program to offer GLP-1 drugs and corresponding medical care to individuals struggling with obesity or weight loss issues. Pairing personalized coaching with GLP-1s is the key to effective weight loss treatment, Reitano said, and helping patients maximize their results. A new real-time approach to weight managementReitano said it should not be an either/or scenario involving diabetes management of weight loss and that will change over the next decade.
0 next >>
Total: 6